Cite
Supplementary Figure 1 from Perillyl Alcohol for the Treatment of Temozolomide-Resistant Gliomas
MLA
Thomas C. Chen, et al. Supplementary Figure 1 from Perillyl Alcohol for the Treatment of Temozolomide-Resistant Gliomas. Apr. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....42440b4f5b588ce2eeb36d3cb518786a&authtype=sso&custid=ns315887.
APA
Thomas C. Chen, Florence M. Hofman, Axel H. Schönthal, Stan G. Louie, Nicos A. Petasis, Tong Xu, Amir Goldkorn, David Jungpa Lee, Michelle N. Leong, Joshua Tseng, Shering Torres, Niyati Jhaveri, Weijun Wang, & Hee-Yeon Cho. (2023). Supplementary Figure 1 from Perillyl Alcohol for the Treatment of Temozolomide-Resistant Gliomas.
Chicago
Thomas C. Chen, Florence M. Hofman, Axel H. Schönthal, Stan G. Louie, Nicos A. Petasis, Tong Xu, Amir Goldkorn, et al. 2023. “Supplementary Figure 1 from Perillyl Alcohol for the Treatment of Temozolomide-Resistant Gliomas,” April. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....42440b4f5b588ce2eeb36d3cb518786a&authtype=sso&custid=ns315887.